Patient Perspective: Cardiac Amyloidosis

Scripps Health

M. Nichols

HFpEF or Amyloidosis? The Right Therapies for Right Patients

Scripps Health

M. Kittleson

Cardiac Amyloidosis: An Overlooked but Treatable Cause of HFpEF

Inova Heart and Vascular Institute - Advanced Heart Failure Symposium

SOHO 2022: Amyloidosis - Update and How To Use Novel Agents

SOHO 2022 Tenth Annual Meeting

S. Lentzsch

Amyloidosis Types and Pathophysiology

Houston Methodist

B. Trachtenberg

Cardiac Amyloidosis: A New Era of Diagnostics and Therapeutics

UCLA Health

D. Vucicevic

Emerging Therapies in Cardiac Amyloidosis

NYU Langone

M. Hanna

New Diagnostic and Treatment Strategies in Cardiac Amyloidosis

Canadian Collaborative Research Network

M. Davis

CHEST 2023 Insights: Interstitial Lung Abnormality (ILA)

CHEST 2023 Insights

S. Raoof

ACC 2023: Practice-Changing Recommendations from the 2021 Chest Pain…

ACC 2023 Conference Coverage

R. Bullock-Palmer

Therapies for Pulmonary Venous Hypertension: Updates on the Treatmen…

Scripps Health

R. Mohan

Cardiac Amyloidosis: Evaluation and New Therapies

Cleveland Clinic Heart, Vascular and Thoracic Institute

M. Hanna

ACC 2022: Clinical Utility of Myocardial Blood Flow Assessment With …

ACC 2022 Conference Coverage

R. Thompson

Overview of Cardiac Amyloidosis

Yale Cancer Center

E. Miller

Interpreting a PYP Study for TTR Cardiac Amyloid

American Society of Nuclear Cardiology

P. Soman, M. Harinstein, S. Divakaran

Lessons from the 2023 ACC Expert Consensus Decision Pathway on Compr…

Michelle Kittleson

Imaging in Cardiomyopathy

Scripps Health

A. Srivastava

A Short Conversation: How Nuclear Cardiology Has Changed and It's Re…

American Society of Nuclear Cardiology

R. Bonow, M. Harinstein, S. Abohashem

Clinical Presentation of Amyloidosis: Who to Suspect? - a 2022 Update

Scripps Health

R. Mohan

Interesting Cases: Multimodality Imaging CMR and PET

Houston Methodist DeBakey Heart and Vascular Center

M. Salerno, M. Al-Mallah, R. Lang, J. Tajik, W. Zoghbi, D. Shah